Pivot Pharmaceuticals Inc. is an emerging biotechnology company founded in 2002. It is dedicated to developing novel therapeutics aimed at addressing unmet medical needs in the realm of women’s health. The company has built a pipeline of drug candidates targeting gynecological and triple-negative breast cancers, focusing on a novel mechanism to combat these conditions. Leveraging its proprietary technologies, Pivot Pharmaceuticals aims to repurpose approved drugs to create a portfolio of innovative therapies for gynecological disturbances, with plans to bring these new treatments to market by 2019. The company operates in the Biopharma, Biotechnology, and Health Care industries, positioning itself at the intersection of cutting-edge biopharmaceutical innovation and pressing medical needs in the field of women's health.
There is no investment information
No recent news or press coverage available for Pivot Pharmaceuticals Inc..
We care about your data, and we'd love to use cookies make your experience better.
